Yesterday’s decision by the U.S. Supreme Court not to hear a challenge to a controversial Arkansas law that blocks medication-induced abortions cleared the way for that law to go into effect.
State Medicaid Programs’ Coverage for Long-Acting Reversible Contraception is Uneven, Study Finds
State Medicaid programs must cover family planning services, but wide variation in specific policies around payment and training means low-income women's access to some of the most effective methods of contraception can vary by state. Researchers who analyzed nine states' Medicaid policies around long-acting reversible contraceptives (LARC) found most did not explicitly cover all key elements of quality contraceptive care.
A Case for Continuing to Fund Title X
“Title X family planning clinics play a critical role in ensuring access to a broad range of family planning and preventive health services,” according to the Department of Health and Human Services website. HHS administers the program, which was created in the 1970s with bi-partisan supported and signed into law by President Richard Nixon.
Why FDA Should Implement Some of the National Academies’ Recommendations for Making Medicines Affordable
As the National Academies of Sciences, Engineering, and Medicine points out in a recent report, Making Medicines Affordable: A National Imperative, the U.S. biopharmaceutical sector has been successful in developing and delivering effective drugs for improving health and fighting disease over the past decades. Many medical conditions that were long deemed untreatable can now be cured or managed effectively.